| UPSA Switzerland AG - Dafalgan DOLO, Tabletten |
| 47504 | | 01 | | Dafalgan DOLO | | Tabletten | | N02BE01 | | Paracetamol | | 03.12.1986 | | |
|
| Composition |
| paracetamolum 500 mg, hypromellosum, povidonum, carmellosum natricum conexum corresp. natrium ca. 1 mg, cellulosum microcristallinum, glyceroli dibehenas, magnesii stearas pro compresso. |
| Packungsbestandteile |
| Tablets | | | | | Active Agent | Dose |
|---|
| Paracetamol | 500 mg |
| | BAG: Active Agent | Dose |
|---|
| Paracetamol | 500 mg |
| | | | Inactive agents |
|---|
| Carmellosum Natricum Conexum | | Cellulosum Microcristallinum | | Glyceroli Dibehenas | | Hypromellosum | | Magnesii Stearas pro Compresso | | Povidone |
| |
|
| Teilbarkeit |
| | kA | | | | Möglich | | | | Möglich | | | | -- | | | | Viele Alternativen | | | | | |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 16 | PR | PR | D | | No |
|
